By Nigel Roberts, London Correspondent

An aging population and burgeoning public debt mean the healthcare sector faces a huge economic and social challenge serving the public in the 21st century. Can we have it both better and cheaper? A report from the INSEAD Alumni Healthcare Summit in London.

Faced with a deadly and expensive diabetes epidemic, Gulf states are looking at innovative business marketing techniques to promote healthy behaviour and keep a cap on spiralling health costs.

  • Drug companies world-wide are under pressure. The rise of generics, looming patent expirations and the expanding innovation gap are creating cost pressures from every direction. Could outsourcing R&D be one way to ease the pain? One former...

  • North American online health advice seekers have long been served by WebMD. Now an ex-Google developer is aiming at the rest of the world with Medico.com.

  • No longer content to be cost and talent arbitrage destinations, emerging markets are becoming hotbeds of innovation, says SD Shibulal, co-founder of Infosys Technologies, one of India's leading IT firms

  • The emerging markets with their populations in the billions have become a potent source of revenue. The representatives of companies in India, Brazil and China have made it clear they do not plan to leave these emerging markets to the Western...

  • With ageing populations in the West and with drug targets improving thousandfold since the mapping of the human genome less than 10 years ago, few industries can look forward to the kind of growth expected in healthcare.